Global M&A deal kickoffs rise 31% in H1 2026 as healthcare and industrials overtake tech, but EMEA completion rates lag at 37%
Datasite, which facilitates around 16,000 new deals annually across M&A, IPO (initial public offering), restructuring and related work, has reported a 31% rise in global deal kickoffs in the first half of 2026 compared to the same period a year earlier. The data is drawn from activity on its platform, where transactions are typically launched months before any public announcement, making it a leading indicator of deal flow later in 2026 and into 2027. Regional growth was uneven. The Americas led with a 52% increase in deal kickoffs, while EMEA (Europe, Middle East and Africa) posted a more modest 13% rise. APAC grew 4%. Despite the surge in launches, global completion rates held broadly steady at 45%, with EMEA lagging at 37%, pointing to persistent regulatory scrutiny, valuation gaps and execution risk in the region. Sectorally, the recovery is broader than previous M&A cycles. Healthcare led all sectors with a 32% rise in deal kickoffs globally, supported by demographic trends, pharmaceutical innovation and AI-assisted drug discovery. Industrials and energy and power each rose 25%, driven by automation investment and data-centre-linked energy demand. TMT (technology, media and telecommunications) grew only 2%, a sharp reversal from its traditional dominance. Buyer composition is also shifting. Corporate strategic acquirers on the platform rose 28% globally, outpacing private equity users who grew 23%. The median preparation time for a deal fell to 12 days from 14 a year earlier, though overall diligence time remained unchanged at 181 days. Rusty Wiley, chief executive of Datasite, noted that "more dealmakers are moving from waiting to preparing" even as uncertainty persists.
Why this matters
The 31% global jump in deal kickoffs is a structurally important signal for City law firms because pipeline data on Datasite's platform tends to precede public announcements by several months, meaning the M&A mandates now being assembled will translate into live instructions in Q3 and Q4 2026. The EMEA completion rate of 37% against a global rate of 45% tells a specific story: European deals are starting but not closing at the same rate, which points to continued regulatory friction from competition authorities and persistent bid-ask valuation spreads rather than a lack of appetite. The sector rotation away from TMT toward healthcare and industrials matters for firm strategy, as it redirects deal flow toward practice teams with sector-specific expertise in pharma, life sciences, and infrastructure. The narrowing median preparation time suggests sellers are running tighter, more competitive processes, putting a premium on advisers who can mobilise quickly.
On the Ground
A recovery in deal kickoffs at this scale generates demand across corporate M&A, leveraged finance, antitrust clearance, and financing advisory practices simultaneously. Firms with strong healthcare and industrials sector groups are best positioned to capture mandates as those sectors lead volume. Regulatory clearance work, particularly in EMEA where completion rates lag, will be especially active as competition authority review timelines continue to weigh on deal execution. No specific advisers are named in the sources. A trainee on a live M&A matter at this stage of a deal would be drafting conditions-precedent checklists, indexing due diligence reports, preparing SPA (sale and purchase agreement) schedules, and maintaining the completion bible as documents are assembled.
Interview prep
Question you might get
“Deal kickoff data is rising but EMEA completion rates are lagging. What does that tell you about the risks facing M&A advisers in Europe right now?”
Sign up free to see the full answer
A model answer you can lift into an interview — how to frame this story for a partner.
Sign up freeMy notes
saved